Exchange Traded Concepts’s Emergent Biosolutions EBS Stock Holding History

Exchange Traded Concepts’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,363	Closed	-$364K	–	1205
2022 Q3	$364K	Buy	17,363 +2,394	+16%	+$66.6K	0.01%	580
2022 Q2	$465K	Buy	14,969 +2,535	+20%	+$86.5K	0.01%	541
2022 Q1	$511K	Buy	+12,434	New	+$548K	0.01%	649
2021 Q3	–	Sell	-4,233	Closed	-$267K	–	1143
2021 Q2	$267K	Buy	4,233 +216	+5%	+$13.9K	0.01%	722
2021 Q1	$373K	Sell	4,017 -41	-1%	-$4.2K	0.01%	641
2020 Q4	$364K	Buy	4,058 +458	+13%	+$42K	0.02%	489
2020 Q3	$372K	Buy	+3,600	New	+$388K	0.02%	377

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exchange Traded Concepts's EBS Position: Q4 2022 in Review

Exchange Traded Concepts sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 17,363 shares — an estimated $364K sold.

Exchange Traded Concepts first reported a position in EBS in Q3 2020 and held it in 7 quarters. The position peaked at $511K in Q1 2022. 198 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

Exchange Traded Concepts reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
Exchange Traded Concepts sold 17,363 Emergent Biosolutions shares in Q4 2022, an estimated $364K.
Exchange Traded Concepts first reported a position in Emergent Biosolutions in Q3 2020 and held it in 7 quarters.
Exchange Traded Concepts's Emergent Biosolutions position peaked at $511K in Q1 2022.
198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Exchange Traded Concepts's 13F filing for Q4 2022, filed 18 Jan 2023.